The ALRCaN webinar on Friday, June 12, 2026, from 09:00 to 10:00 AM ET, will present “Long-term follow-up of the CALGB 10403 trial: New insights into AYA ALL.”

Presented by Dr. Wendy Stock, this session delivers critical updates and data-driven insights from the long-term follow-up of this landmark trial, focusing on clinical outcomes for adolescent and young adult acute lymphoblastic leukemia patients. Hosted by Resonance as part of their weekly Friday network series, the collegial gathering facilitates expert discussion on pediatric-inspired regimens and supportive care strategies to optimize global patient outcomes.